News from Parichehr Bahraini, HAE Iran Hereditary Angioedema (HAE) International Day at the Immunology, Asthma, and Allergy Research Institute...

From Arbia Barhoun, HAE Tunisia Hereditary Angioedema Patients' Meeting in Tunisia A meeting of angioedema patients affiliated with the Tunisian...

From HAE Panama During the month of May, the Panamanian Association of Hereditary Angioedema Patients carried out various awareness and visibility...

From Edison Galarraga, HAE EcuadorEvaluation of the prevalence of sleep disorders in severe and uncontrolled patients with HAE in EcuadorWith great...

"Hereditary Angioedema Market" Hereditary Angioedema Companies are Ionis Pharmaceuticals, Astria Therapeutics, KalVista Pharmaceuticals, Intellia...

Approval of sebetralstat from European Union and Swiss regulatory authorities A new medicine for HAE, called Ekterly (sebetralstat), has received...

Intellia shares surge nearly 30% as the company completes enrollment in its pivotal phase III HAELO study on lonvo-z for hereditary angioedema.

Intellia shares surge nearly 30% as the company completes enrollment in its pivotal phase III HAELO study on lonvo-z for hereditary angioedema.

From Ana Freitas, HAE Portugal hae day :-) event: The Portuguese association (ADAH) organized a symbolic walk, with the active participation of its...

From Meryam Jennane, Secretary, HAE Morocco Uniting for change: Building bridges for HAE patients in Morocco Promising progress is currently underway...